Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Shares Outstanding (2016 - 2025)

Assembly Biosciences has reported Shares Outstanding over the past 11 years, most recently at $15.9 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $15.9 million for Q4 2025, up 112.62% from a year ago — trailing twelve months through Dec 2025 was $15.9 million (up 112.62% YoY), and the annual figure for FY2025 was $15.9 million, up 112.62%.
  • Shares Outstanding for Q4 2025 was $15.9 million at Assembly Biosciences, roughly flat from $15.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding for ASMB hit a ceiling of $48.5 million in Q3 2022 and a floor of $4.0 million in Q4 2021.
  • Median Shares Outstanding over the past 5 years was $7.5 million (2024), compared with a mean of $18.8 million.
  • Biggest five-year swings in Shares Outstanding: crashed 90.99% in 2023 and later skyrocketed 148.91% in 2025.
  • Assembly Biosciences' Shares Outstanding stood at $4.0 million in 2021, then increased by 1.61% to $4.1 million in 2022, then surged by 34.56% to $5.5 million in 2023, then soared by 36.01% to $7.5 million in 2024, then surged by 112.62% to $15.9 million in 2025.
  • The last three reported values for Shares Outstanding were $15.9 million (Q4 2025), $15.8 million (Q3 2025), and $7.7 million (Q2 2025) per Business Quant data.